Published in BMJ Open on May 26, 2016
Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess (2004) 29.45
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ (2003) 11.21
Designing and evaluating complex interventions to improve health care. BMJ (2007) 9.78
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J (2013) 3.58
Effect of adding systematic family history enquiry to cardiovascular disease risk assessment in primary care: a matched-pair, cluster randomized trial. Ann Intern Med (2012) 3.57
Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis (1999) 3.33
Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ (2002) 2.55
Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J (2008) 2.50
Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ (2000) 2.40
Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart (2007) 1.91
Estimated 10-year cardiovascular risk in a British population: results of a national screening project. Int J Clin Pract (2008) 1.75
Identification and management of familial hypercholesterolaemia: what does it mean to primary care? Br J Gen Pract (2009) 1.55
Collecting genetic information in primary care: evaluating a new family history tool. Fam Pract (2005) 1.23
The effectiveness of recruitment strategies on general practitioner's survey response rates - a systematic review. BMC Med Res Methodol (2014) 1.16
Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia. Curr Med Res Opin (2010) 0.96
Assessing family history of heart disease in primary care consultations: a qualitative study. Fam Pract (2007) 0.93
Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT). Atherosclerosis (2014) 0.85
A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice. Heart (2016) 0.81
Systematic detection of familial hypercholesterolaemia in primary health care: a community based prospective study of three methods. Heart Lung Circ (2014) 0.81
Availability and quality of coronary heart disease family history in primary care medical records: implications for cardiovascular risk assessment. PLoS One (2014) 0.81
Realising the potential of the family history in risk assessment and primary prevention of coronary heart disease in primary care: ADDFAM study protocol. BMC Health Serv Res (2009) 0.80
The reduced cost of providing a nationally recognised service for familial hypercholesterolaemia. Open Heart (2014) 0.79
The potential role of an expert computer system to augment the opportunistic detection of individuals with familial hypercholesterolaemia from a community laboratory. Clin Chim Acta (2015) 0.78
Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia. Curr Opin Lipidol (2015) 0.77
Improving detection of familial hypercholesterolaemia in primary care using electronic audit and nurse-led clinics. J Eval Clin Pract (2015) 0.77